# Pilot Placebo Controlled Study With Lovaza in Cardiovascular Disease

> **NCT01001767** · PHASE2 · COMPLETED · sponsor: **University Hospitals Cleveland Medical Center** · enrollment: 35 (actual)

## Conditions studied

- HIV Infections
- Heart Disease

## Interventions

- **DRUG:** Lovaza
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01001767
- **Lead sponsor:** University Hospitals Cleveland Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2010-03
- **Final completion:** 2010-06
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2015-01-07

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01001767

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01001767, "Pilot Placebo Controlled Study With Lovaza in Cardiovascular Disease". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01001767. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*